Evaluation of bronchodilator responses in chronic obstructive pulmonary disease patients Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002
A comparison of the effects of lung function between low dose theophylline and oral β2-agonist in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 215s Year: 2006
The effect of short-acting beta-two-agonist on pulmonary rehabilitation in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease Year: 2009
Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006
Effect of long-term bronchodilator therapy on pulmonary function tests and exercise tolerance in patients with stable chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002
Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009
Bronchodilatory effects of formoterol in patients with chronic obstructive pulmonary disease (COPD) are not influenced by concomitant corticosteroid use Source: Eur Respir J 2001; 18: Suppl. 33, 514s Year: 2001
Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 427s Year: 2003
A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Correlation between the pulmonary hemodynamic and spirometric parameters in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 25s Year: 2002
The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005
Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) and COPD concomitant with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 521s Year: 2004
FEV1 is not sufficient for assessing bronchodilator reversibility in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 121s Year: 2004
Effects of different classes of bronchodilators on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease> Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019
The efficacy of formoterol in patients with chronic obstructive pulmonary disease (COPD) is not influenced by concomitant corticosteroid use Source: Eur Respir J 2001; 18: Suppl. 33, 515s Year: 2001
The effect of dipyrone on respiratory function in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004
Efficacy of long-acting bronchodilator inhalation on postoperative pulmonary function and quality of life in lung cancer patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Actual challenges in thoracic surgery Year: 2008
The effect of nutrition on the pulmonary functions in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 538s Year: 2003
Modern treatment of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 60S-66S Year: 2001
Efficacy of lasolvan in the treatment of patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Drug effects in COPD Year: 2009